Stockreport

Merck's Keytruda meets response endpoint in late-stage study in first-line lung cancer; shares ahead 2% premarket [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck's Keytruda meets response endpoint in late-stage study in first-line lung cancer; shares ahead 2% premarketMerck (NYSE:MRK) is up2% premarket on light volume on th [Read more]